跳至主要内容
临床试验/NCT05405504
NCT05405504Unknown不适用

Evaluation of ReDS Pro System V2.7 and ReDS ICU in Patients With Heart Failure

Christian Hassager1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2022年6月13日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
25
试验地点
1
主要终点
Correlation between ReDS ICU fluid parameters and Swan-Ganz measurements

研究概览

简要总结

The study is an investigator-initiated, prospective cohort trial. The trial aims to evaluate ReDS Pro System V2.7 and ReDS ICU in patients with heart failure (HF).

详细描述

The study is an investigator-initiated, prospective cohort trial. The trial aims to evaluate ReDS Pro System V2.7 and ReDS ICU in patients with heart failure (HF). The overall purposes are:

  • to evaluate the ReDS efficacy measurements of lung fluid compared to pulmonary artery pressure guided therapy with CardioMEMS in out-patients with HF.
  • to describe the feasibility of ReDS ICU in patients admitted to an ICU with HF

For the out-patient part, the patients will be recruited from the outpatient clinic at Rigshospitalet. The patient must be at least 18 years, have a history of chronic HF, and already monitored using CardioMEMS and must not fulfill any of the exclusion criteria.

For the ICU part, the patients will be recruited at the ICU department at the Heart Center at Rigshospitalet. The patient must be at least 18 years, intubated, and unconscious or sedated (Glasgow Coma Score <8), and already monitored using Swan-Ganz and arterial catherization and must not fulfill any of the exclusion criteria.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • at least 18 years of age
  • hospitalized in ICU setting at Rigshospitalet
  • intubated
  • unconscious or sedated (Glasgow Coma Score <8)
  • monitored using Swan-Ganz and arterial catherization.
  • Out-patient part:
  • at least 18 years of age
  • history of Chronic heart failure > 3 months
  • CardioMEMS

排除标准

  • pacemaker or ICD on the right side
  • congenital heart malformations or intra-thoracic mass that would affect the right lung anatomy (e.g. dextrocardia, lung carcinoma)
  • wounds, burns, healing tissue, skin infection or recent skin graft or flap where the sensors should be attached to the skin
  • habitus is out of range due to one or more of the following
  • height less than 155 cm or higher than 195 cm
  • estimated BMI of less than 22 or more than 36
  • standard active therapy has been stopped as the patient is inevitably dying.
  • Out-patient part:
  • pacemaker or ICD on the right side
  • congenital heart malformations or intra-thoracic mass that would affect the right lung anatomy (e.g. dextrocardia, lung carcinoma)
  • wounds, burns, healing tissue, skin infection or recent skin graft or flap where the sensors should be attached to the skin
  • habitus is out of range due to one or more of the following Height less than 155 cm or higher than 195 cm BMI of less than 22 or more than 38 For BMI 36 to 38, chest size ruler should be 39 or less
  • cancer or other severe non-cardiac disease with estimated life expectancy less than 1 year
  • planned hospitalization for ICD, pacemaker, lung or heart surgery including heart transplantation during the study period.

结局指标

主要结局

Correlation between ReDS ICU fluid parameters and Swan-Ganz measurements

时间窗: Daily Swan-Ganz catheter and ReDS ICU measurements the first 72 hours after Swan-Ganz implantation

Measurements on Swan-Ganz catheter (CVP, PAP, PCWP - all in mmHg) and the percentage of fluid in the lungs (%)

Correlation between ReDS v2.7 fluid parameters and CardioMEMS measurements

时间窗: 3 months

mPAP (mmHg), dPAP (mmHg) and the percentage of fluid in the lungs (%)

次要结局

  • Changes in ReDS ICU fluid parameters following changes in Positive End Expiratory Pressure(During the first 72 hours after Swan-Ganz implantation)
  • Changes in ReDS ICU fluid parameters following changes administration of diuretics and inotropic/inodilators(During the first 72 hours after Swan-Ganz implantation)
  • Changes in ReDS ICU fluid parameters following changes in body position(During the first 72 hours after Swan-Ganz implantation)
  • Correlation between ReDS v2.7 fluid parameters and body weight(3 months)
  • Changes in ReDS ICU fluid parameters following raised leg test(During the first 72 hours after Swan-Ganz implantation)
  • Correlation between ReDS v2.7 fluid parameters and dyspnea symptom evaluated by NYHA class.(3 months)

研究者

发起方
Christian Hassager
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Christian Hassager

MD, DMSc, Professor in Cardiology

Rigshospitalet, Denmark

研究点 (1)

Loading locations...

相似试验